Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer.
Mfn2 downregulation significantly associated with disease progression.
»
08/02/21
The Involvement of Natural Polyphenols in the Chemoprevention of Cervical Cancer.
In last years emphasis on alternative medicine, more specifically on phytochemicals.
»
07/19/21
Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial.
Fifty-two percent of inactive patients accepted the intervention.
»
04/08/21
Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma.
Nuclear OCT4 positive genotype indicated aggressive tumor behavior.
»
08/25/21
Epigenetic therapies in ovarian cancer alter repetitive element expression in a TP53-dependent manner.
Cell lines with TP53 mutations exhibited significantly fewer upregulated REs.
»
08/24/21
Immune checkpoint inhibitors at any treatment line in advanced NSCLC: Real-world overall survival in a large Italian cohort.
Treatment with anti PD-1/PD-L1 at any line lowered hazard of death.
»
04/22/21
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat.
Another HDAC inhibitor, valproic acid, also more effective against IDH1-mut glioma cells.
»
06/10/21
Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment.
FDA has approved Sipuleucel-T for treatment of asymptomatic or minimally symptomatic mCRPC.
»
08/09/21
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
AEs infrequently required permanent discontinuation of oral azacitidine.
»
08/28/21
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Dependency between aldehyde dehydrogenase ALDH2 and BRCA-interacting protein BRIP1.
»
08/28/21
< Prev
Next >